ADC Therapeutics (ADCT) Research & Development (2020 - 2026)
ADC Therapeutics (ADCT) posted Research & Development of $19.9 million for Q1 2026, down 25.84% sequentially from $26.8 million in Q3 2025, and down 31.29% YoY from $28.9 million in Q1 2025.
ADC Therapeutics (ADCT) Research & Development (2020 - 2026) Analysis & Trends
ADC Therapeutics has reported Research & Development for 7 years, with the latest figure at $19.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | ADC Therapeutics | 148.95 Mn | -70.15 Mn | 17.14 Mn | 17.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.37 Mn |
| Mar 31, 2026 | 19.88 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 30.09 Mn |
| Mar 31, 2025 | 28.93 Mn |
| Sep 30, 2024 | 32.50 Mn |
| Jun 30, 2024 | 24.30 Mn |
| Mar 31, 2024 | 25.74 Mn |
| Sep 30, 2023 | 27.08 Mn |
| Jun 30, 2023 | 31.34 Mn |
| Mar 31, 2023 | 39.48 Mn |
| Sep 30, 2022 | 41.68 Mn |
| Jun 30, 2022 | 48.54 Mn |
| Mar 31, 2022 | 48.95 Mn |
| Sep 30, 2021 | 36.81 Mn |
| Jun 30, 2021 | 39.53 Mn |
| Mar 31, 2021 | 39.17 Mn |
| Sep 30, 2020 | 32.16 Mn |
| Jun 30, 2020 | 25.95 Mn |
| Mar 31, 2020 | 35.38 Mn |